文献速递性腺与生殖内分泌

LMNA基因罕见变异在两个独立队列中与多囊卵巢综合征发病相关

Rare Variation in LMNA Underlies Polycystic Ovary Syndrome Pathogenesis in 2 Independent Cohorts.
PubMed 文献 · J Clin Endocrinol Metab · 2025-01-01

在两个独立队列中,对多囊卵巢综合征(PCOS)患者和健康对照进行LMNA基因测序。发现队列中15/811例患者和1/172例对照携带变异,与gnomAD非芬兰欧洲人群对照相比OR=2.9(P=3.7×10-5);验证队列中15/718例患者和1/281例对照携带变异,OR=4.0(P=3.4×10-8)。LMNA变异识别出伴高甘油三酯和极端胰岛素抵抗的PCOS患者。

要点

  • LMNA罕见错义变异与PCOS可重复关联,发现队列OR=2.9,验证队列OR=4.0。
  • LMNA变异识别的PCOS患者具有高甘油三酯和极端胰岛素抵抗特征。
  • LMNA变异所致PCOS表型与遗传性部分脂肪营养不良综合征存在重叠。

核心结论

  • LMNA罕见错义变异与PCOS可重复关联,并识别出部分具有脂肪营养不良样特征的个体。
  • 该PCOS表型与遗传性部分脂肪营养不良综合征的重叠值得进一步研究其他脂肪营养不良基因及其在PCOS病因中的潜在作用。

研究设计与样本

  • 发现队列:对811例PCOS患者和164例健康对照进行LMNA靶向测序。
  • 验证队列:对718例PCOS患者和281例健康对照的全外显子组测序数据中的LMNA进行分析。

主要发现

  • 发现队列中15/811例患者和1/172例生殖健康对照携带LMNA变异,与gnomAD非芬兰欧洲人群对照相比χ2=17,P=3.7×10-5,OR=2.9。
  • 验证队列中15/718例患者和1/281例生殖健康对照携带11个独特变异,与人群对照相比χ2=30.5,P=3.4×10-8,OR=4.0。
  • 在发现队列和验证队列中,LMNA变异均识别出伴高甘油三酯和极端胰岛素抵抗的PCOS女性。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Polycystic ovary syndrome (PCOS) is a common, heritable endocrinopathy that is a common cause of anovulatory infertility in reproductive age women. Variants in LMNA cause partial lipodystrophy, a syndrome with overlapping features to PCOS. OBJECTIVE: We tested the hypothesis that rare variation in LMNA contributes to PCOS pathogenesis and selects a lipodystrophy-like subtype of PCOS. METHODS: We sequenced LMNA by targeted sequencing a Discovery cohort of 811 PCOS patients and 164 healthy controls. We then analyzed LMNA from whole-exome sequencing of a Replication cohort of 718 PCOS patients and 281 healthy controls. We evaluated variation in the LMNA gene and hormone and lipid profiles of participants. RESULTS: In the Discovery cohort, we identified 8 missense variants in 15/811 cases, and 1 variant in 1/172 reproductively healthy controls. There is strong evidence for association between the variants and PCOS compared to gnomAD non-Finnish European population controls (χ2 = 17, P = 3.7 × 10-5, OR = 2.9). In the Replication cohort, we identified 11 unique variants in 15/718 cases, and 1 variant in 281 reproductively healthy controls. Again, there is strong evidence for association with population controls (χ2 = 30.5, P = 3.4 × 10-8, OR = 4.0). In both the Discovery and Replication cohorts, variants in LMNA identify women with PCOS with high triglycerides and extreme insulin resistance. CONCLUSION: Rare missense variation in LMNA is reproducibly associated with PCOS and identifies some individuals with lipodystrophy-like features. The overlap between this PCOS phenotype and genetic partial lipodystrophy syndromes warrants further investigation into additional lipodystrophy genes and their potential in PCOS etiology.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Bauer R, Parker C, Gorsic LK, et al. Rare Variation in LMNA Underlies Polycystic Ovary Syndrome Pathogenesis in 2 Independent Cohorts. J Clin Endocrinol Metab. 2025. PMID: 39484826. doi:10.1210/clinem/dgae761

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。